PD-L1 Expression and Survival among Patients with Advanced Non–Small Cell Lung Cancer Treated with ChemotherapySteffen Filskov Sorensen, Henrik Hager, Wei Zhou et al.|Translational Oncology|2016Cited by 90
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung TrialSolange Peters, Egbert F. Smit, Ana López et al.|Journal of Thoracic Oncology|2016Cited by 22
Pd-L1 Expression and Survival Among Advanced Non–Small Cell Lung Cancer (Nsclc) Patients Treated with ChemotherapySteen Sørensen, Henrik Hager, Wei Zhou et al.|Annals of Oncology|2014Cited by 6
Abstract 570: PD-L1 expression in paired non-small cell lung cancer tumor samplesHenrik Hager, Steffen Filskov Sorensen, Zhen Wang et al.|Cancer Research|2015Cited by 0